Mesco Pharmaceuticals Ltd.
| BSE: 500274 | Sector: Health care |
| NSE: MESCOPHARM | ISIN Code: INE839X01015 |
| BSE 00:00 | 10 Jan | Mesco Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan | Mesco Pharmaceuticals Ltd |
| OPEN | 4.54 |
| PREVIOUS CLOSE | 4.54 |
| VOLUME | 700 |
| 52-Week high | 5.69 |
| 52-Week low | 3.61 |
| P/E | |
| Mkt Cap.(Rs cr) | 9 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Mesco Pharmaceuticals Ltd. (MESCOPHARM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 523.15 | -15.45 | -2.87 | 15823.68 |
| Cipla | 971.35 | 0.85 | 0.09 | 13900.58 |
| Dr Reddy's Labs | 4304.95 | -46.15 | -1.06 | 13349.10 |
| Sun Pharma.Inds. | 911.15 | 0.95 | 0.10 | 12803.21 |
| Lupin | 590.30 | -10.85 | -1.80 | 11055.93 |
| Apollo Hospitals | 3525.75 | -106.65 | -2.94 | 9153.00 |
| Zydus Lifesci. | 366.25 | -1.90 | -0.52 | 7790.40 |
| Glenmark Pharma. | 386.75 | -7.80 | -1.98 | 7567.93 |
| Alkem Lab | 2967.65 | 35.25 | 1.20 | 7219.68 |
| Divi's Lab. | 3518.70 | -143.35 | -3.91 | 6798.61 |
| Torrent Pharma. | 2634.55 | 42.05 | 1.62 | 6450.83 |
| Ipca Labs. | 938.00 | -17.60 | -1.84 | 5114.11 |
| Alembic Pharma | 741.00 | -15.35 | -2.03 | 5051.44 |
| Laurus Labs | 553.95 | -13.20 | -2.33 | 4768.72 |
| Abbott India | 18068.30 | -123.50 | -0.68 | 4310.02 |
| Gland Pharma | 2743.50 | -128.15 | -4.46 | 3462.88 |
| Glaxosmi. Pharma | 1525.20 | -28.55 | -1.84 | 3193.74 |
| Granules India | 254.15 | -26.60 | -9.47 | 3134.98 |
| Sanofi India | 6503.50 | -84.30 | -1.28 | 2956.60 |
| Ajanta Pharma | 1701.25 | 1.95 | 0.11 | 2718.59 |
Quick Links for Mesco Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
